Evidence map›Paper›PMID 27811104›Full record

ArticleGenome announcements2016

Finished Genome Sequence of the Highly Multidrug-Resistant Human Urine Isolate Citrobacter freundii Strain SL151.

Tomasz A Leski, Chris R Taitt, Umaru Bangura, Rashid Ansumana, David A Stenger, Zheng Wang, Gary J Vora

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genome announcements, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Applied and environmental microbiology · 2022
    Article
  2. Genetic Diversity, Multidrug Resistance, and Virulence ofFrontiers in cellular and infection microbiology · 2018
    Article
  3. Antimicrobial Resistance and Cytotoxicity ofFrontiers in microbiology · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Tomasz A LeskiCenter for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington, District of Columbia, USA.ORCID http://orcid.org/0000-0001-7688-9887
Chris R TaittCenter for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington, District of Columbia, USA.
Umaru BanguraMercy Hospital Research Laboratory, Bo, Sierra Leone.
Rashid AnsumanaMercy Hospital Research Laboratory, Bo, Sierra Leone.
David A StengerCenter for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington, District of Columbia, USA.
Zheng WangCenter for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington, District of Columbia, USA.
Gary J VoraCenter for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory, Washington, District of Columbia, USA gary.vora@nrl.navy.mil.ORCID http://orcid.org/0000-0002-0657-8597

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Citrobacter freundii is a Gram-negative opportunistic pathogen that is increasingly being recognized as a causative agent of hospital-acquired urinary tract infections and an important reservoir of antimicrobial resistance determinants. In this report, we describe the finished genome sequence of C. freundii strain SL151, a highly multidrug-resistant human urine isolate.

Identifiers

PMID27811104
PMCPMC5095474

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.